Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Science (008930 KS)
Watchlist
70
Analysis
Health Care
•
South Korea
Hanmi Science Co., Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
E Mart Inc
•
20 Feb 2025 16:23
Growing Importance of ACT - Korea's Largest Minority Shareholders Platform
In this insight, we discuss about the growing importance of ACT, the largest minority shareholders platform (https://www.act.ag/) in Korea with...
Douglas Kim
Follow
655 Views
Share
bullish
•
Jb Financial Group
•
11 Dec 2024 18:20
KRX Value-Up Special Rebalance in December: Playbook & Screening Rundown
KRX is likely to announce the Value Up Index results after tomorrow’s close. Add count’s basically a done deal—5 names in the bag. KB, Hana, and...
Sanghyun Park
Follow
1.1k Views
Share
bearish
•
Quantitative Analysis
•
04 Dec 2024 06:00
KRX Short Interest Weekly (Nov 29th):Korea Zinc, JYP, SK Hynix
We analyzed KRX short interest report for the past week and highlighted short interest changes in Korea Zinc, JYP, SK Hynix.
Ke Yan, CFA, FRM
Follow
500 Views
Share
bullish
•
Young Poong
•
02 Oct 2024 04:13
Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2024
In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
739 Views
Share
bearish
•
Quantitative Analysis
•
07 Aug 2024 06:00
KRX Short Interest Weekly (Aug 2nd): Sk Hynix, Korea Aerospace, Posco
We analyzed KRX short interest report for the past week and highlighted short interest changes in Sk Hynix, Korea Aerospace, Posco.
Ke Yan, CFA, FRM
Follow
435 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x